A detailed history of Massmutual Trust CO Fsb transactions in Glaukos Corp stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 50 shares of GKOS stock, worth $6,545. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50
Previous 50 -0.0%
Holding current value
$6,545
Previous $5,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 02, 2024

BUY
$89.48 - $118.35 $178 - $236
2 Added 4.17%
50 $5,000
Q4 2023

Jan 03, 2024

BUY
$59.53 - $85.11 $1,666 - $2,383
28 Added 140.0%
48 $3,000
Q3 2023

Oct 03, 2023

BUY
$69.23 - $79.09 $830 - $949
12 Added 150.0%
20 $1,000
Q2 2023

Aug 01, 2023

SELL
$45.44 - $71.21 $545 - $854
-12 Reduced 60.0%
8 $0
Q1 2023

Apr 11, 2023

BUY
$43.88 - $52.48 $877 - $1,049
20 New
20 $1,000
Q3 2022

Oct 07, 2022

BUY
$46.84 - $58.49 $796 - $994
17 New
17 $1,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.23B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Massmutual Trust CO Fsb Portfolio

Follow Massmutual Trust CO Fsb and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Massmutual Trust CO Fsb with notifications on news.